YOLFTbeta
68

Insight Lifetech Co., Ltd.

688712 · SHG · Healthcare / Medical Devices

27.27CNY-0.73 (-2.61%)

Price History

Full chart

Market Stats

Previous Close28.00
Open28.00
Day Range27.08 – 28.10
52-Week Range26.46 – 55.80
Volume1.31M
Market Cap12.09B
P/E (TTM)90.63
Forward P/E0.00
EPS0.32
Dividend Yield0.00%
50-Day Avg29.78
200-Day Avg36.66

About

Insight Lifetech Co., Ltd. engages in research, development, production, and sales of interventional medical devices in the field of precision diagnosis and treatment of cardiovascular diseases in China and internationally. The company provides Coronary intervention products, including precision and complex percutaneous coronary intervention products, such as intracavitary imaging and physiological function products; peripheral vascular interventional diagnostic and treatment products; and electrophysiological products. It offers TruePhysio rapid exchange pressure microcatheter, VivoHeart intravascular ultrasound console, VivoCardio cardiovascular pressure measurement system, TRUEVISION HD imaging catheter, TrueCross microcatheter, TrueReach dual-lumen microcatheter, and TrueExtensio guide extension catheter. The company also provides clinical support and academic promotion related to its products, and engages in research and development, manufacturing, and commercialization of medical technologies. Insight Lifetech Co., Ltd. was incorporated in 2015 and is headquartered in Shenzhen, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Liang Song
  • Employees673
  • HeadquartersBuilding 3, Tingwei Industrial Park, Shenzhen, China, 518101, China
  • Websitehttps://www.insight-med.com

Leadership

  • Mr. Liang SongChairman & CEO · b. 1982
  • Ms. Fei LianDeputy GM, CFO & Director · b. 1987
  • Ms. Miao LuoChief Compliance Officer · b. 1986
  • Mr. Rui LuoSecretary · b. 1988
  • Mr. Lin LiDeputy General Manager · b. 1984
  • Mr. Pengtao ZhangDeputy General Manager · b. 1986
  • Mr. Heng Wei LiR & D Director · b. 1988

Financials

Income Statement

Currency: CNY2022-12-312023-12-312024-12-312025-12-31
Total Revenue92.45M183.98M316.60M542.09M
Growth (%)-+99.00%+72.09%+71.22%
Cost of Revenue33.74M64.36M116.16M163.21M
Gross Profit58.71M119.62M200.44M378.88M
Gross Margin63.51%65.02%63.31%69.89%
Operating Expense410.85M308.95M272.43M298.36M
Operating Income-352.14M-189.33M-71.99M80.51M
Operating Margin-380.89%-102.91%-22.74%14.85%
EBITDA-313.63M-146.61M-30.11M120.47M
EBITDA Margin-339.24%-79.69%-9.51%22.22%
Net Income-290.04M-139.77M-43.60M80.02M
Net Income Margin-313.72%-75.97%-13.77%14.76%
R&D131.95M131.41M101.43M88.54M
R&D as % of Total Revenue142.73%71.43%32.04%16.33%
Interest Expense1.36M1.50M1.69M1.51M
Interest Expense % of Total Revenue1.47%0.81%0.53%0.28%

Balance Sheet

Currency: CNY2022-12-312023-12-312024-12-312025-12-31
Total Assets854.33M779.91M783.00M948.12M
Total Liabilities100.36M119.29M136.75M186.79M
Total Equity768.57M690.66M686.43M809.37M
Cash32.10M35.99M15.04M62.73M
Net Debt--14.99M-

Cash Flow

Currency: CNY2022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-161.02M-137.84M29.91M145.37M
Capital Expenditure41.95M17.42M16.79M30.46M
Free Cash Flow-202.97M-155.25M13.12M114.91M
Dividends Paid-437.50K912.50K267.91K
FCF to OCF126.05%112.63%43.87%79.05%
Dividend Paid to FCF--0.28%6.95%0.23%

Key Statistics & Ratios

Market Cap12.09B
Enterprise Value11.02B
Trailing P/E90.63
Forward P/E0.00
Price / Sales16.84
Price / Book6.46
EPS0.32
Book Value4.27
Revenue (TTM)718.20M
Gross Profit (TTM)510.51M
EBITDA160.98M
Profit Margin18.20%
Operating Margin23.54%
Return on Equity9.76%
Return on Assets6.20%
Shares Outstanding417.00M
Shares Float149.38M
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%